Di Fazio I - Search Results

1

Efficacy of different schedules in the management of chronic hepatitis C with interferon-alpha.

Malaguarnera M, Di Fazio I, Restuccia S, Pistone G, Restuccia N, Trovato BA. Malaguarnera M, et al. Among authors: di fazio i. Ann Med. 1998 Apr;30(2):213-7. doi: 10.3109/07853899808999406. Ann Med. 1998. PMID: 9667801 Free article. Clinical Trial.

2

Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis C.

Di Fazio I, Motta M, Musumeci S, Neri S, Pistone G, Malaguarnera M. Di Fazio I, et al. J Interferon Cytokine Res. 2004 Oct;24(10):594-9. doi: 10.1089/jir.2004.24.594. J Interferon Cytokine Res. 2004. PMID: 15626156

3

Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus.

Malaguarnera M, Di Fazio I, Romeo MA, Restuccia S, Laurino A, Trovato BA. Malaguarnera M, et al. Among authors: di fazio i. J Gastroenterol. 1997 Apr;32(2):211-5. doi: 10.1007/BF02936370. J Gastroenterol. 1997. PMID: 9085170

4

Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-alpha treatment.

Malaguarnera M, Di Fazio I, Laurino A, Ferlito L, Romano M, Trovato BA. Malaguarnera M, et al. Among authors: di fazio i. Int J Clin Pharmacol Ther. 1997 Sep;35(9):385-8. Int J Clin Pharmacol Ther. 1997. PMID: 9314092 Clinical Trial.

5

Decrease of interferon gamma serum levels in patients with chronic hepatitis C.

Malaguarnera M, Di Fazio I, Laurino A, Pistone G, Restuccia S, Trovato BA. Malaguarnera M, et al. Among authors: di fazio i. Biomed Pharmacother. 1997;51(9):391-6. doi: 10.1016/s0753-3322(97)89432-2. Biomed Pharmacother. 1997. PMID: 9452789

6

Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha.

Malaguarnera M, Di Fazio I, Restuccia S, Pistone G, Ferlito L, Rampello L. Malaguarnera M, et al. Among authors: di fazio i. Neuropsychobiology. 1998;37(2):93-7. doi: 10.1159/000026485. Neuropsychobiology. 1998. PMID: 9566274 Clinical Trial.

7

Rapid evolution of chronic viral hepatitis into hepatocellular carcinoma after beta-interferon treatment.

Malaguarnera M, Restuccia S, Di Fazio I, Di Marco R, Pistone G, Trovato BA. Malaguarnera M, et al. Among authors: di fazio i, di marco r. Panminerva Med. 1999 Mar;41(1):59-61. Panminerva Med. 1999. PMID: 10230260

8

Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C.

Malaguarnera M, Laurino A, Di Fazio I, Pistone G, Castorina M, Guccione N, Rampello L. Malaguarnera M, et al. Among authors: di fazio i. J Interferon Cytokine Res. 2001 May;21(5):273-8. doi: 10.1089/107999001300177457. J Interferon Cytokine Res. 2001. PMID: 11429157

9

Alpha-interferon (IFN-alpha) treatment of chronic hepatitis C: analysis of some predictive factors for the response.

Malaguarnera M, Di Fazio I, Trovato BA, Pistone G, Mazzoleni G. Malaguarnera M, et al. Among authors: di fazio i. Int J Clin Pharmacol Ther. 2001 Jun;39(6):239-45. Int J Clin Pharmacol Ther. 2001. PMID: 11430631 Clinical Trial.

10

Use of interleukin-2 in advanced renal carcinoma: meta-analysis and review of the literature.

Malaguarnera M, Ferlito L, Gulizia G, Di Fazio I, Pistone G. Malaguarnera M, et al. Among authors: di fazio i. Eur J Clin Pharmacol. 2001 Jul;57(4):267-73. doi: 10.1007/s002280100321. Eur J Clin Pharmacol. 2001. PMID: 11549203 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters